THE HARLEQUIN SURGERY
160 SHARD END CRESCENT, BIRMINGHAM
STIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 195 | 218 | 89.4% | |
| STROKE 9 | 2006 | 219 | 236 | 92.8% | |
| Stroke 12 | 2007 | 222 | 235 | 94.5% | |
| Stroke 12 | 2008 | 228 | 238 | 95.8% | |
| Stroke 12 | 2009 | 230 | 237 | 97.0% | |
| Stroke 12 | 2010 | 268 | 281 | 95.4% | |
| STROKE 12 | 2011 | 251 | 262 | 95.8% | |
| STROKE 12 | 2012 | 236 | 253 | 93.3% | |
| STROKE 12 | 2013 | 213 | 229 | 93.0% | |
| STIA007 | 2014 | 219 | 222 | 98.6% | |
| STIA007 | 2015 | 213 | 214 | 99.5% | |
| STIA007 | 2016 | 187 | 189 | 98.9% | |
| STIA007 | 2017 | 185 | 188 | 98.4% | |
| STIA007 | 2018 | 178 | 182 | 97.8% | |
| STIA007 | 2019 | 180 | 181 | 99.4% | |
| STIA007 | 2020 | 179 | 182 | 98.4% | |
| STIA007 | 2021 | 151 | 169 | 89.3% | |
| STIA007 | 2022 | 166 | 176 | 94.3% | |
| STIA007 | 2023 | 165 | 170 | 97.1% |
